" /> Gray platelet syndrome - CISMeF





Preferred Label : Gray platelet syndrome;

Symbol : GPS;

CISMeF acronym : BDPLT4; GPS;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Bleeding disorder, platelet-type, 4; BDPLT4; Platelet alpha-granule deficiency;

Description : The gray platelet syndrome (GPS) is a rare inherited disorder characterized by mild to moderate bleeding tendency, moderate thrombocytopenia, and a marked decrease or absence of platelet alpha-granules and of the proteins contained in alpha-granules. The platelets are enlarged, but not giant, and have a gray appearance on light microscopy of Wright-stained peripheral blood smears due to decreased granules. Many patients with gray platelet syndrome develop a stable myelofibrosis (summary by Nurden and Nurden, 2007). Cases suggesting autosomal dominant and autosomal recessive inheritance have been described, indicating that GPS is probably a genetically heterogeneous disorder with more than one molecular cause.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the neurobeachin-like 2 gene (NBEAL2, 614169.0001).;

Laboratory abnormalities : Low-to-normal platelet count; Median mean platelet volume 13fl; Prolonged bleeding time (10 - 30 minutes); Increased serum vitamin B12; Reduced platelet aggregation response to collagen and thrombin; Platelets have decreased number of alpha-granules, large vacuoles, normal number of dense bodies on electron microscopy; Decreased von Willebrand factor; Decreased platelet factor 4; Decreased beta-thromboglobulin; Decreased thrombospondin; Decreased fibrinogen; Decreased platelet derived growth factor; Decreased fibronectin; Normal platelet aggregation response to arachidonic acid (AA);

Prefixed ID : #139090;

Details


You can consult :


Nous contacter.
25/10/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.